Waters Corporation (NYSE:WAT) introduced ACQUITY™ PREMIER Columns, a new family of premium sub-2-micron columns featuring MaxPeak™ High Performance Surface (HPS) technology.

BioChromato Inc. reports that the pharmacokinetics department at a leading Japanese pharmaceutical company has found that RAPID Slit Seals offer significant benefits compared to conventional silicone mats for maintaining the integrity of microplate samples.

BioChromato Inc. reports how the Department of Bioimaging Information Analysis at Gunma University (Japan) is benefiting from the ability of its Smart Evaporator C1 to safely and efficiently concentrate low volume samples.

BioGX, a molecular diagnostics solutions company, announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19.

Targeting analysis of biological particles with large aspect ratios, such as viruses or fibrils, CEA scientists have demonstrated a breakthrough in single-particle mass spectrometry (MS) that could fast track the detection of viral particles in hospitals, offices, airplanes and other public places.

Specialty chemicals manufacturer FAR Chemical is using Matrix Gemini LIMS to improve the efficiency of its operations By significantly reducing the time taken to test and approve samples in the laboratory, the hold-times of products in the reactors have been cut and the efficiency of the entire operation improved.

Metrohm is proud to announce the launch of the Misa. Misa is Metrohm’s newest Raman spectrometer that detects trace contaminants in even the most complex food samples.

Synthace Ltd has launched a new software capability for streamlining a fundamental workhorse of biochemistry: the enzyme-linked immunosorbent assay (ELISA).

10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a definitive agreement to acquire ReadCoor, Inc., for cash and stock consideration of $350 million. The announcement follows 10x Genomics’ acquisition of Stockholm-based CartaNA AB, developers of In Situ RNA analysis technology,

The BD FACSDuet™ Sample Preparation System enables clinical laboratories to fully automate the sample to answer process and improve their efficiency, by reducing errors and limiting the manual user interactions required to run assays on the BD FACSLyric™ Flow Cytometer.